DEMZX Performance — Nomura Emerging Markets Fund, Class R6
Data updated: 2026-07-27
DEMZX returned +102.91% year to date and +239.68% over one year to May 2026. Annualised returns are +66.04% over 3 years and +25.48% over 5 years. The fund beat its Emerging Markets Equity category average: $100 invested three years ago grew to $458, against $186 for the category, and to $340 over one year, against $149. Volatility over the past three years was 36.62% a year. In the 12 months to May 2026 the fund lost a net $1.5B, and assets reached $14.45B.
DEMZX Growth of $100
What $100 invested in Nomura Emerging Markets Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Emerging Markets Equity category average over the same months.
| Period | DEMZX | Category average |
|---|---|---|
| 1 year (Jun 2025 – May 2026) | $340 | $149 |
| 3 years (Jun 2023 – May 2026) | $458 | $186 |
| 5 years (Jun 2021 – May 2026) | $311 | $145 |
| Since data start (Sep 2019 – May 2026) | $490 | $202 |
DEMZX Trailing Returns
Total returns to May 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +102.91% |
| 1 year | +239.68% |
| 3 years (annualised) | +66.04% |
| 5 years (annualised) | +25.48% |
DEMZX Annual Returns
Calendar-year total returns of Nomura Emerging Markets Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–May) | +102.91% |
| 2025 | +87.21% |
| 2024 | +6.59% |
| 2023 | +17.76% |
| 2022 | −28.60% |
| 2021 | −1.94% |
| 2020 | +25.96% |
| 2019 (Sep–Dec) | +16.59% |
DEMZX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +25.3% | +10.6% | −17.6% | +36.7% | +30.0% | — | — | — | — | — | — | — |
| 2025 | +5.4% | −1.4% | −0.5% | −0.1% | +8.2% | +17.0% | −2.1% | +0.2% | +15.0% | +15.9% | −1.1% | +10.6% |
| 2024 | −3.3% | +7.8% | +5.1% | −2.3% | +3.4% | +8.0% | −3.4% | −1.3% | +2.9% | −4.5% | −3.6% | −1.1% |
| 2023 | +10.9% | −7.1% | +4.2% | −4.0% | +1.1% | +3.5% | +5.8% | −5.7% | −2.9% | −2.0% | +10.2% | +4.4% |
| 2022 | −1.8% | −7.5% | −5.2% | −6.1% | +1.8% | −8.4% | −0.7% | −0.6% | −12.1% | −4.0% | +17.2% | −3.1% |
| 2021 | +3.2% | +2.6% | −2.8% | +2.8% | +1.5% | +0.2% | −9.6% | −0.2% | −1.2% | +0.7% | −2.0% | +3.6% |
| 2020 | −5.4% | −5.9% | −17.2% | +12.7% | +3.1% | +9.9% | +12.6% | +1.5% | −0.9% | +0.8% | +7.8% | +8.8% |
| 2019 | — | — | — | — | — | — | — | — | +1.9% | +4.7% | +1.3% | +7.9% |
DEMZX Risk
Risk measures from monthly returns over Jun 2023 – May 2026.
- 3-year volatility (annualised): 36.62%
- 3-year Sharpe ratio: 1.68 (vs 4.5% risk-free rate)
- Best month: +36.70% (Apr 2026)
- Worst month: −17.63% (Mar 2026)
DEMZX Fund Flows
Monthly money in and out of Nomura Emerging Markets Fund, from SEC Form N-PORT.
- 12-month net flow: −$1.5B
- 12-month gross sales (incl. reinvestments): $4.1B
- Sales ÷ redemptions: 0.74×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| May 2026 | $391.3M | $1.7B | −$1.3B |
| Apr 2026 | $323.0M | $428.9M | −$105.9M |
| Mar 2026 | $366.2M | $446.0M | −$79.8M |
| Feb 2026 | $477.7M | $614.8M | −$137.1M |
| Jan 2026 | $349.8M | $660.8M | −$311.0M |
| Dec 2025 | $1.4B | $459.1M | $971.4M |
| Nov 2025 | $156.7M | $394.0M | −$237.3M |
| Oct 2025 | $164.0M | $290.6M | −$126.6M |
| Sep 2025 | $164.0M | $146.5M | $17.5M |
| Aug 2025 | $88.8M | $151.4M | −$62.5M |
| Jul 2025 | $129.0M | $172.1M | −$43.1M |
| Jun 2025 | $93.1M | $129.8M | −$36.7M |
DEMZX Assets Under Management
Net assets of Nomura Emerging Markets Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-05-29 | $14.45B |
| 2026-02-27 | $11.05B |
| 2025-11-28 | $7.98B |
| 2025-08-29 | $6.32B |
| 2025-05-30 | $5.63B |
| 2025-02-28 | $5.29B |
| 2024-11-29 | $5.24B |
| 2024-08-30 | $5.54B |
| 2024-05-31 | $5.34B |
| 2024-02-29 | $5.15B |
| 2023-11-30 | $4.82B |
| 2023-08-31 | $4.71B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.